Treatment tapering and stopping in patients with rheumatoid arthritis in stable remission (RETRO): a multicentre, randomised, controlled, open-label, phase 3 trial (2021) Tascilar K, Hagen M, Kleyer A, Simon D, Reiser M, Hueber A, Manger B, et al. Journal article COVID-19 and immune-mediated inflammatory diseases: effect of disease and treatment on COVID-19 outcomes and vaccine responses (2021) Fagni F, Simon D, Tascilar K, Schoenau V, Sticherling M, Neurath M, Schett G Journal article, Review article Targeting GM-CSF in rheumatological conditions: risk of PAP Reply (2021) Genovese MC, Buckley CD, Saurigny D, Schett G, Davy K, Gupta A, Smith JE, et al. Journal article, Letter Quantification of Ga-68-FAPI-04 in systemic sclerosis-associated interstitial lung disease Reply (2021) Distler J, Bergmann C, Kuwert T, Schmidkonz C Journal article, Letter Quantification of 68Ga-FAPI-04 in systemic sclerosis-associated interstitial lung disease – Authors' reply (2021) Distler J, Bergmann C, Kuwert T, Schmidkonz C Journal article Targeting GM-CSF in rheumatological conditions: risk of PAP – Authors' reply (2021) Genovese MC, Buckley CD, Saurigny D, Schett G, Davy K, Gupta A, Smith JE, et al. Journal article Circulating collagen neo-epitopes and their role in the prediction of fibrosis in patients with systemic sclerosis: a multicentre cohort study (2021) Dobrota R, Jordan S, Juhl P, Maurer B, Wildi L, Bay-Jensen AC, Karsdal MA, et al. Journal article Long-term effect of tocilizumab in patients with giant cell arteritis: open-label extension phase of the Giant Cell Arteritis Actemra (GiACTA) trial (2021) Stone JH, Han J, Aringer M, Blockmans D, Brouwer E, Cid MC, Rech J, et al. Journal article 68Ga-FAPI-04 PET-CT for molecular assessment of fibroblast activation and risk evaluation in systemic sclerosis-associated interstitial lung disease: a single-centre, pilot study (2021) Bergmann C, Distler J, Treutlein C, Tascilar K, Müller A, Atzinger A, Matei AE, et al. Journal article Anti-granulocyte-macrophage colony-stimulating factor antibody otilimab in patients with hand osteoarthritis: a phase 2a randomised trial (2020) Schett G, Bainbridge C, Berkowitz M, Davy K, Fernandes S, Griep E, Harrison S, et al. Journal article